-
Likelihood of Approval and Phase Transition Success Rate Model - Dofetilide in Atrial Fibrillation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dofetilide in Atrial Fibrillation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dofetilide in Atrial Fibrillation Drug Details: HYCVS-033 (dofetilide) is under development...
-
Likelihood of Approval and Phase Transition Success Rate Model - BGB-10188 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGB-10188 in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGB-10188 in Small-Cell Lung Cancer Drug Details: BGB-10188 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - IRO-203 in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IRO-203 in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IRO-203 in Coronavirus Disease 2019 (COVID-19) Drug Details: IRO-203...
-
Likelihood of Approval and Phase Transition Success Rate Model - Vilastobart in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vilastobart in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vilastobart in Cervical Cancer Drug Details: XTX-101 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - Vilastobart in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vilastobart in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vilastobart in Fallopian Tube Cancer Drug Details: XTX-101 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - ADM-03820 in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ADM-03820 in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ADM-03820 in Coronavirus Disease 2019 (COVID-19) Drug Details: ADM-03820...
-
Likelihood of Approval and Phase Transition Success Rate Model - JTV-263 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JTV-263 in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JTV-263 in Peripheral Arterial Disease...
-
Likelihood of Approval and Phase Transition Success Rate Model - MET-233i in Overweight
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MET-233i in Overweight report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MET-233i in Overweight Drug Details: MET-233i is under development for the treatment...
-
Likelihood of Approval and Phase Transition Success Rate Model - Rotigotine in Parkinson's Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rotigotine in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rotigotine in Parkinson's Disease Drug Details: Rotigotine (MFP-013) is under development...
-
Likelihood of Approval and Phase Transition Success Rate Model - COVID-19 Prime-2-CoV in Coronavirus Disease 2019 (COVID-19)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - COVID-19 Prime-2-CoV in Coronavirus Disease 2019 (COVID-19) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. COVID-19 Prime-2-CoV in Coronavirus Disease 2019 (COVID-19) Drug...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.